Go to content or main menu
14-09-2018 | 12:00
The Medicines Evaluation Board (MEB) intends to intensify collaboration with its partner authority in Switzerland in the field of ...
06-09-2018 | 16:00
The United Kingdom (UK) is leaving the European Union in March 2019. The terms on which the UK is going to leave the EU are still ...
19-07-2018 | 16:00
The 5th issue of the Medicines Evaluation Board’s Regulatory Science Magazine is now available. This issue focuses on ...
13-07-2018 | 08:00
Update for marketing authorisation holders The Falsified Medicines Directive (FMD) (Directive 2011/62/EU) are measures to prevent ...
15-06-2018 | 11:00
Review of 2018 MEB Day Innovation and quick and careful registration. How do we make sure that regulations do not get too much in ...
11-06-2018 | 15:00
The Medicines Evaluation Board (MEB) has amended its policy for Direct Healthcare Professional Communications (DHPCs) and the ...
29-03-2018 | 13:00
The 2017 annual report of the Medicines Evaluation Board (MEB) has been published. Use this opportunity to look back on what ...
02-03-2018 | 13:40
The fourth issue of the Medicines Evaluation Board’s Regulatory Science Magazine is appearing today. The focus this time is on ...
15-01-2018 | 22:30
Scientific advice from the MEB improves and speeds up the development of medicines The Medicines Evaluation Board (MEB) is going ...
18-12-2017 | 14:00
On 22 February 2018 a pilot will start for companies with medicinal products under additional monitoring. As from that date ...
12-12-2017 | 12:30
The Medicines Evaluation Board (MEB) believes that the discussion about expensive medicines should not just focus on costs. ...
28-11-2017 | 10:00
Last week, the Medicines Evaluation Board (MEB) called for more attention in reporting possible side effects of medicines. ...
24-11-2017 | 12:00
Prof. O.M. (Olaf) Dekkers was sworn in as a new member of the Medicines Evaluation Board (MEB) on 23 November 2017.
20-11-2017 | 18:15
The Medicines Evaluation Board (MEB) is pleased to welcome the European Medicines Agency (EMA) to Amsterdam. In its declaration ...
14-11-2017 | 10:30
On Wednesday 1 November 2017 a mini symposium was organised to mark the retirement of Dr Christine Gispen-de Wied, manager of the ...
30-10-2017 | 15:00
The Medicines Evaluation Board (MEB) has amended the national policy for labelling medicinal products for human use (MEB 6). As a ...
26-10-2017 | 12:00
The United Kingdom has decided to leave the European Union on 29 March 2019. This has consequences for the regulation of ...
16-10-2017 | 10:00
The new EudraVigilance system for the reporting and analysis of suspected adverse reactions (ADRs) to medicinal products, will ...
